drugset

drugset / Trial / NCT00168415

A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis

NCT00168415 ↗

Phase 4 Completed 144 enrolled Allergan

Non-randomizedSingle-groupOpen-labelTreatment

Summary

A study using Botulinum Toxin Type A in adolescents with axillary hyperhidrosis.

Timeline

Start: 2005-08
Primary completion: 2007-06
Completion: 2007-06

Publications

Glaser DA, Pariser DM, Hebert AA, Landells I, Somogyi C, Weng E, Brin MF, Beddingfield F. A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis. Pediatr Dermatol. 2015 Sep-Oct;32(5):609-17. doi: 10.1111/pde.12620. Epub 2015 Jun 8.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Botulinum toxin type A	Protein / enzyme biologic	100 iu	—

Indications